X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Experimental Hematology & Oncology

期刊標題檢索 EXP HEMATOL ONC 最新評論: 5-18 Submission 6-3 Resubmission after format modification 6-8 Revi... (2022-09-02)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Experimental Hematology & Oncology]您好,您是該頁面的第 22182 位訪客。

期刊簡介
期刊名稱Experimental Hematology & Oncology Experimental Hematology & Oncology
LetPub Score
6.0
50 ratings
Rate

Reputation
7.2

Influence
4.9

Speed
7.1

期刊簡稱EXP HEMATOL ONCOL
ISSN2162-3619
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.602.3841.583
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q142 / 404
Category: Medicine
Subcategory: Hematology
Q117 / 137
Category: Medicine
Subcategory: Cancer Research
Q135 / 230

自引率 (2023-2024)6.40%自引率趨勢
掲載範囲
Experimental Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology with emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with "negative" or preliminary results and basic science studies with provocative findings.
官方網站https://www.springer.com/journal/40164
在線稿件提交https://www.editorialmanager.com/EXHO
開放訪問Yes
出版商BioMed Central
主題領域Medicine
出版國/地區ENGLAND
發行頻率
創刊年2012
每年文章數71每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP2490; USD3190; EUR2790; )
APC waiver:Check Notes
Other charges: No
Keywords: haematology、oncology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ19/97
ONCOLOGYSCIEQ132/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-3619%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 6 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Experimental Hematology & Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature CancerH-index: 0

    CiteScore: 31.10
    JAMA OncologyH-index: 41

    CiteScore: 37.50
    JAMA OncologyH-index: 61

    CiteScore: 37.50
    Trends in CancerH-index: 0

    CiteScore: 28.50
    Liver CancerH-index: 25

    CiteScore: 20.80
    ESMO OpenH-index: 0

    CiteScore: 11.70
    Cancer Biology & MedicineH-index: 29

    CiteScore: 9.80
    Annual Review of Cancer BiologyH-index: 0

    CiteScore: 14.50
    CancersH-index: 53

    CiteScore: 8.00
    Translational Lung Cancer ResearchH-index: 0

    CiteScore: 7.20
    學科內最受檢索的期刊 頁面查看次數
    Cancers209498
    OncoTargets and Therapy183265
    Cancer Management and Research149109
    Journal of Oncology88244
    Cancer Biology & Medicine58478
    Molecular Therapy-Oncolytics43575
    JAMA Oncology36960
    Liver Cancer34134
    Nature Cancer33324
    Translational Lung Cancer Research29415
  •  

    Experimental Hematology & Oncology Experimental Hematology & Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Experimental Hematology & Oncology] 的評論撰寫評論
作者: 萧赢


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-02 20:48:47 評論於
5-18 Submission
6-3 Resubmission after format modification
6-8 Reviewer's comment
8-9 Revision
8-12 Resubmission
8-13 Reviewer's comment
8-26 Major revision
8-27 Resubmission
8-29 Invite another reviewer
8-30 Reviewer's comment
8-30 Minor revision
8-31 Resubmission again
9-2 Acceptance
(0) 讚! | 萧赢

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Experimental Hematology & Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*